Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2007 by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Wake Forest University
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00383279
First received: September 29, 2006
Last updated: May 9, 2009
Last verified: October 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
RATIONALE: Finding out which problems affect employment in survivors of gynecologic cancer may help in planning cancer treatment and improve the quality of life of future cancer survivors.
PURPOSE: This research study is looking at ways to improve employment in patients who have survived cervical cancer, uterine cancer, or ovarian cancer.
| Condition | Intervention |
|---|---|
|
Cervical Cancer Ovarian Cancer Sarcoma |
Other: counseling intervention Other: study of socioeconomic and demographic variables |
| Study Type: | Interventional |
| Official Title: | Improving Employment Among Gynecologic Cancer Survivors |
Resource links provided by NLM:
MedlinePlus related topics:
Cancer
Cervical Cancer
Ovarian Cancer
Soft Tissue Sarcoma
Uterine Cancer
U.S. FDA Resources
Further study details as provided by National Cancer Institute (NCI):
Primary Outcome Measures:
- Development of a structured interview instrument [ Designated as safety issue: No ]
- Recruitment strategy [ Designated as safety issue: No ]
| Estimated Enrollment: | 70 |
| Study Start Date: | February 2006 |
| Estimated Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
OBJECTIVES:
- Conduct formative work, including 4 to 5 focus groups, leading to development of a structured interview instrument assessing factors related to employment outcomes among women with gynecologic cancers.
- Pilot a recruitment strategy and administer the interview among a sample of 60 to 70 gynecologic cancer survivors; and, with each woman's permission, a family member, a key health care provider, and her supervisor will be interviewed.
OUTLINE: This is a multicenter, pilot study.
Patients complete a survey, meet with a focus group, and undergo a short interview. Patient-designated participants are also interviewed; these individuals may include a health care provider, a significant other, and/or a work supervisor.
PROJECTED ACCRUAL: A total of 70 patients will be accrued for this study.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
DISEASE CHARACTERISTICS:
Diagnosis of 1 of the following invasive cancers:
- Cervical cancer
- Uterine cancer
- Ovarian cancer
- Diagnosed ≥ 6 months ago
- Any stage disease
- Employed at the time of diagnosis, defined as working for pay ≥ 20 hours/week
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00383279
Locations
| United States, North Carolina | |
| Wake Forest University Comprehensive Cancer Center | |
| Winston-Salem, North Carolina, United States, 27157-1096 | |
Sponsors and Collaborators
Wake Forest University
Investigators
| Principal Investigator: | Brigitte E. Miller, MD | Comprehensive Cancer Center of Wake Forest University |
More Information
Additional Information:
No publications provided
| ClinicalTrials.gov Identifier: | NCT00383279 History of Changes |
| Other Study ID Numbers: | CDR0000491031, CCCWFU-99106, CCCWFU-BG06-014 |
| Study First Received: | September 29, 2006 |
| Last Updated: | May 9, 2009 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Cancer Institute (NCI):
|
recurrent cervical cancer stage 0 cervical cancer stage IA cervical cancer stage IB cervical cancer stage IIA cervical cancer stage IIB cervical cancer stage III cervical cancer stage IVA cervical cancer stage IVB cervical cancer recurrent uterine sarcoma stage I uterine sarcoma stage II uterine sarcoma stage III uterine sarcoma stage IV uterine sarcoma |
borderline ovarian surface epithelial-stromal tumor ovarian sarcoma ovarian stromal cancer recurrent ovarian epithelial cancer recurrent ovarian germ cell tumor stage I ovarian epithelial cancer stage I ovarian germ cell tumor stage II ovarian epithelial cancer stage II ovarian germ cell tumor stage III ovarian epithelial cancer stage III ovarian germ cell tumor stage IV ovarian epithelial cancer stage IV ovarian germ cell tumor |
Additional relevant MeSH terms:
|
Uterine Cervical Neoplasms Ovarian Neoplasms Sarcoma Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Neoplasms by Site Neoplasms Uterine Cervical Diseases |
Uterine Diseases Genital Diseases, Female Endocrine Gland Neoplasms Ovarian Diseases Adnexal Diseases Endocrine System Diseases Gonadal Disorders Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type |
ClinicalTrials.gov processed this record on May 21, 2013